ARK Innovation ETF (ARKK)

Some investors may think that the Federal Reserve has tamed inflation risks, but recent price action in some assets suggests that reinflation trades are on.

Trading earnings report reactions are one of the riskiest trading strategies. However, when asymmetrical risk and reward apply favorably, then the the upside

Although Cathie Wood sold Nvidia in 2023, she continues to invest in artificial intelligence via her long position in UiPath stock

As Bitcoin hits a two-year peak, Ark fund manager Cathie Wood makes strategic portfolio changes ahead of regulators' decision on the first spot Bitcoin ETF.

Taking a closer look at top-performing tech-focused ETFs like QQQ, XLK, and ARKK and unlocking the potential of innovation and diversification.

Cloudflare shares are up 6% in the past three months, rebounding from a decline after its Q1 report. The company guided toward 650% EPS growth this year.

As inflation moderates, Investors are optimistic for the second quarter earnings season and that optimism is evident in some of the top stories from this week

If you're a believer in the progress of science and technology and feel strongly that our best days are still ahead, then a slice of ARKK could be tempting.

Verve Therapeutics' efforts to eliminate cardiovascular disease through gene-editing treatments have momentum, as the stock gets a 20.74% boost in June.

Exact Sciences sees a bump in stock price amid rising revenue and study results that show advancements to its flagship Cologuard colorectal screening product.

Twilio stock surges on activist pressure and Cathie Wood's investment, as the company faces revenue challenges amid restructuring efforts to prioritize profit.

The return and risk profiles of these three ‘hedgies’ are among the best in the business, making them well worth following.

Small-cap Immunocore has been a price leader within the biotech industry. Analysts have a "buy" rating on the stock and estimate that it will move 25% higher.

The markets are trending lower to end the week. It’s hard to figure out the markets after the blockbuster job report, but the MarketBeat team gave it a shot

Can gains in Tesla, Zoom, Exact Sciences, and other growth stocks set the stage for Cathie Woods' Ark Innovation Fund to stage a comeback in 2023?

Cathie Wood is known for her deep understanding of tech companies and for holding aggressive long positions in her tech funds. Let's look at what she's buying.

Zoom Video (NASDAQZM) has gone from an obscure but easy-to-use video communications platform to becoming a verb synonymous with video conferencing

Unity Software has been on a wild ride after reporting better-than-expected earnings, but then rejecting a buyout offer by AppLovin. Is it ready to rally again?